Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents ; day:17 ; month:4 ; year:2018 ; pages:1-8
Clinical research in cardiology ; (17.4.2018), 1-8
- Urheber
-
Varenhorst, Christoph
- Beteiligte Personen und Organisationen
-
Lindholm, Martin
Sarno, Giovanna
Olivecrona, Göran
Jensen, Ulf
Nilsson, Johan
Carlsson, Jörg
James, Stefan
Lagerqvist, Bo
SpringerLink (Online service)
- DOI
-
10.1007/s00392-018-1252-0
- URN
-
urn:nbn:de:101:1-2018062119373804495951
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Varenhorst, Christoph
- Lindholm, Martin
- Sarno, Giovanna
- Olivecrona, Göran
- Jensen, Ulf
- Nilsson, Johan
- Carlsson, Jörg
- James, Stefan
- Lagerqvist, Bo
- SpringerLink (Online service)
Ähnliche Objekte (12)
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation
The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Drug-eluting stent for acute Blalock-Taussig shunt thrombosis in a child—case report
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation
The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Drug-eluting stent for acute Blalock-Taussig shunt thrombosis in a child—case report
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis
Drug-Eluting Coronary Stents: Hypersensitivity Reactions to Paclitaxel - A Case Report
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation
The potential hazard of drug-eluting stent-induced coronary vasospasm causing subacute stent thrombosis: a case report
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
Comparison of the safety and efficacy of biodegradable polymer drug-eluting stents versus durable polymer drug-eluting stents: a meta-analysis
Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating
Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
Drug-eluting stent for acute Blalock-Taussig shunt thrombosis in a child—case report
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Bioresorbable vascular stents and drug-eluting stents in treatment of coronary heart disease: a meta-analysis